Comparison of Pharmacokinetics and Safety of HS632 and Xolair® With a Single Injection
Clinical trial NCT04361812 · TERMINATED
Trial details
- NCT number
- NCT04361812
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2021-12-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.